Product Information
CEFPROZIL 125 MG/5 ML SUSP is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.1637 per ML under NDC 57237003450. Its NADAC has been published 341 times since Apr 9, 2014.
FDA first approved this application on Jan 30, 2007. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
125 mg/5mL
Manufacturer
Rising Pharma Holdings Inc.NDC
57237003450
Classification
Generic
Dosage Form
POWDER, FOR SUSPENSION
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
CEFPROZILApproval Type
Generic (ANDA)
FDA Application
ANDA065381FDA Approved
1/30/2007
TE Code
AB
On Market Since
1/30/2007
Price Statistics
The NADAC for CEFPROZIL 125 MG/5 ML SUSP has been published 341 times since Apr 9, 2014, and over the history we have for it it has declined 54.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1637 per ML |
|---|---|
| All-time high | $0.3581 (May 14, 2014) |
| All-time low | $0.1195 (Apr 22, 2026) |
| 52-week high | $0.1773 |
| 52-week low | $0.1195 |
| Median price | $0.2363 |
| Average price | $0.2514 |
| Largest weekly change | -24.7% (Apr 17, 2024) |
| Weeks tracked | 341 |
| Tracking since | Apr 9, 2014 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 42% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CEFPROZIL 125 MG/5 ML SUSP?
The current National Average Drug Acquisition Cost (NADAC) for CEFPROZIL 125 MG/5 ML SUSP, manufactured by Rising Pharma Holdings Inc., is $0.1637 per ML (NDC 57237003450), effective Aug 19, 2026.
How has the price of CEFPROZIL 125 MG/5 ML SUSP changed over time?
Over the history we have for it, the NADAC for CEFPROZIL 125 MG/5 ML SUSP has declined 54.3%. It has been tracked across 341 weekly CMS publications since Apr 9, 2014.
What are the highest and lowest recorded NADAC prices for CEFPROZIL 125 MG/5 ML SUSP?
Since Apr 9, 2014, the NADAC for CEFPROZIL 125 MG/5 ML SUSP has ranged from a low of $0.1195 (Apr 22, 2026) to a high of $0.3581 (May 14, 2014), with a median of $0.2363 per ML.
Are there cheaper alternatives to CEFPROZIL 125 MG/5 ML SUSP?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CEFPROZIL 125 MG/5 ML SUSP, is $0.0943 per ML — about 42% below CEFPROZIL 125 MG/5 ML SUSP.
Who manufactures CEFPROZIL 125 MG/5 ML SUSP?
CEFPROZIL 125 MG/5 ML SUSP (NDC 57237003450) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.